The PERMIT project aims to build recommendations for robust and reproducible personalised medicine research. A first stage of the project focuses on performing a review of existing literature to map existing methodologies and identify gaps and opportunities for recommendations. The protocol for this scoping review project has been made publicly available, and now an abstract of this methodology has been published in a special issue of the Cochrane Library, entitled Advances in Evidence Synthesis. This abstract was submitted by the PERMIT project for the Cochrane Colloquium 2020, but due to the COVID-19 pandemic this event was postponed until September 2022. The abstract was nevertheless selected by the organizers to be part of this special edition and can be found online (p403).
@ECRIN_ERIC
Jul 21st
On July 7 the #PERMITproject held its General Assembly. It was an opportunity to reflect on the achievements of the past 6 months, as efforts shift towards drafting recommendations on #personalisedmedicine research.
Learn more: permit-eu.org/article/3rd-pe… https://t.co/MAfW1CcOeF
@EatrisEric
Jul 20th
#CellularModels for #PersonalisedMedicine were the final topic in the #PERMITproject series on #preclinical methods for personalised medicine on 30 June. Read more about the session and outcomes here: permit-eu.org/article/focus-… ECRIN_ERIC https://t.co/DoAx6i9KoE
@ECRIN_ERIC
Jul 16th
The regulatory framework for personalised medicine research can be difficult to navigate. The #PERMITproject gathered over 30 experts to discuss the existing gaps and challenges, and opportunities for recommendations.
permit-eu.org/article/regula… https://t.co/d51JlREWRK
